|
|
|
November 30, 2020 |
|
|
Top Stories
Should more COVID-19 research be based on mucosal immunity?
As most COVID-19 tests are based on nasal swabs or saliva samples that measure the amount of SARS-CoV-2 virus in the mouth or nose, it is important to understand how immunity to the virus develops in these mucous membranes. In a perspective article published in Frontiers in Immunology on November 30, researchers warned that the large mucosal immune system has been understudied during the pandemic.
|
|
|
New evidence shows SARS-CoV-2 mutations are not more transmissible
In direct contrast to previous research, researchers found that SARS-CoV-2 mutations are not tied to increased transmissibility in humans. The findings, published in Nature Communications on November 25 suggest that mutations such as D614G, while common, are neutral to viral evolution.
|
|
|
|
Cancer & Disease Research Sponsored by Beckman Coulter
Regulatory Roundup: antibodies, immunotherapies, expanded flu treatment use
Welcome to this week's edition of Regulatory Roundup. This past week, several novel therapies for the treatment of rare diseases and cancers have received approvals, including monoclonal antibodies, immunotherapy drugs, and a lentiviral gene therapy. Roche also received expanded use approval for its flu treatment.
|
|
|
Covaxx to deliver over 140M vaccine doses to emerging countries
Covaxx, a subsidiary of United Biomedical, has received purchase commitments of more than 140 million doses of its UB-612 COVID-19 vaccine, totaling over $2.8 billion. The vaccine will be delivered to multiple countries including Brazil, Ecuador, and Peru.
|
|
|
|
Cell Biology
Should more COVID-19 research be based on mucosal immunity?
As most COVID-19 tests are based on nasal swabs or saliva samples that measure the amount of SARS-CoV-2 virus in the mouth or nose, it is important to understand how immunity to the virus develops in these mucous membranes. In a perspective article published in Frontiers in Immunology on November 30, researchers warned that the large mucosal immune system has been understudied during the pandemic.
|
|
|
|
Immunology Sponsored by Beckman Coulter
Moderna to file COVID-19 vaccine EUA request today
Moderna said it plans to request on November 30 an emergency use authorization (EUA) from the U.S. Food and Drug Administration and conditional marketing authorization from the European Medicines Agency for its messenger RNA (mRNA)-1273 COVID-19 vaccine candidate.
|
|
|
New evidence shows SARS-CoV-2 mutations are not more transmissible
In direct contrast to previous research, researchers found that SARS-CoV-2 mutations are not tied to increased transmissibility in humans. The findings, published in Nature Communications on November 25 suggest that mutations such as D614G, while common, are neutral to viral evolution.
|
|
|
|
Proteomics
What Your Colleagues are Buzzing About
|
|
|
scienceboard.net, 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA - +1 520-298-1000
Copyright 2020 scienceboard.net. All Rights Reserved.
|